UA43391U - 2-(5-r-aryl-1,2,4-triazole-3-ylthio)acetates that reduce level of triglycerides in blood serum - Google Patents

2-(5-r-aryl-1,2,4-triazole-3-ylthio)acetates that reduce level of triglycerides in blood serum

Info

Publication number
UA43391U
UA43391U UAU200903532U UAU200903532U UA43391U UA 43391 U UA43391 U UA 43391U UA U200903532 U UAU200903532 U UA U200903532U UA U200903532 U UAU200903532 U UA U200903532U UA 43391 U UA43391 U UA 43391U
Authority
UA
Ukraine
Prior art keywords
triazole
ylthio
triglycerides
aryl
acetates
Prior art date
Application number
UAU200903532U
Other languages
Russian (ru)
Inventor
Иван Михайлович Билай
Евгений Сергеевич Пругло
Андрей Григорович Каплаушенко
Андрей Сергеевич Гоцуля
Александр Иванович Панасенко
Евгений Григорович Книш
Original Assignee
Запорожский Государственный Медицинский Университет
Иван Михайлович Билай
Евгений Сергеевич Пругло
Андрей Григорович Каплаушенко
Андрей Сергеевич Гоцуля
Александр Иванович Панасенко
Евгений Григорович Книш
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Запорожский Государственный Медицинский Университет, Иван Михайлович Билай, Евгений Сергеевич Пругло, Андрей Григорович Каплаушенко, Андрей Сергеевич Гоцуля, Александр Иванович Панасенко, Евгений Григорович Книш filed Critical Запорожский Государственный Медицинский Университет
Priority to UAU200903532U priority Critical patent/UA43391U/en
Publication of UA43391U publication Critical patent/UA43391U/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

2-(5-R-aryl-1,2,4-triazole-3-ylthio)acetates containing morpholinium 2-(5-(4-pyridyl)-4-(2-tolyl)-1,2,4-triazole-3-ylthio)acetatetributylammonium 2-(5-methyl-4-(2-methoxyphenyl)-1,2,4-triazole-3ylthio)acetatethat reduce level of triglycerides in blood serum.
UAU200903532U 2009-04-13 2009-04-13 2-(5-r-aryl-1,2,4-triazole-3-ylthio)acetates that reduce level of triglycerides in blood serum UA43391U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU200903532U UA43391U (en) 2009-04-13 2009-04-13 2-(5-r-aryl-1,2,4-triazole-3-ylthio)acetates that reduce level of triglycerides in blood serum

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU200903532U UA43391U (en) 2009-04-13 2009-04-13 2-(5-r-aryl-1,2,4-triazole-3-ylthio)acetates that reduce level of triglycerides in blood serum

Publications (1)

Publication Number Publication Date
UA43391U true UA43391U (en) 2009-08-10

Family

ID=50633787

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU200903532U UA43391U (en) 2009-04-13 2009-04-13 2-(5-r-aryl-1,2,4-triazole-3-ylthio)acetates that reduce level of triglycerides in blood serum

Country Status (1)

Country Link
UA (1) UA43391U (en)

Similar Documents

Publication Publication Date Title
HK1216100A1 (en) 1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro- 2-methylpropan-2-yl)isoxazol-3-yl)urea as raf kinase modulator in the treatment of cancer diseases raf 1-(3-(67--4- ))-3-(5-(111--2--2-)-3-)
MX2011008389A (en) Tosylate salt of a 5-pyrazolyl-2-pyridone derivative, useful in the treatment of copd.
JO3062B1 (en) Crystalline (r)-(e)-2-(4-(2-(5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1h-indazol-3-yl)vinyl)-1h-pyrazol-1-yl)ethanol
IL207854A0 (en) Crystal forms of 5-[3-(2,5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl)[1,2,4]oxadiazol-5-yl]-3-nit robenzene-1,2-diol
MX351848B (en) Crystalline forms of a factor xia inhibitor.
PL2126020T3 (en) Hydrophobically modified polyalkylenimines for use as dye transfer inhibitors
DK2046331T3 (en) Use of 3- (4-amino-1-oxo-1,3-dihydro-isoindol-2-yl) -piperidine-2,6-dione for the treatment of mantle cell lymphoma
PL3252069T3 (en) (11.beta.,17.beta.)-17-hydroxy-11-[4-(methylsulfonyl)phenyl]-17-(pentalfuoromethyl)estra-4,9-dien-3-one for use in the treatment of diseases
EP2560642A4 (en) Treatment of gout
NZ629636A (en) Liver x receptor (lxr) modulators for the treatment of dermal diseases, disorders and conditions
MX368543B (en) MATERIALS and METHODS FOR TREATING DIARRHEA.
PL2370070T3 (en) Pimobendan for use in the treatment of hypertrophic cardiomyopathy in cats.
IL267557B (en) Process for preparing 5-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]methyl]-2,4-thiazolidinedione and salts thereof
HUE054346T2 (en) 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione for treating nonalcoholic fatty liver disease
HK1218857A1 (en) 3, 3, 4, 4 -tetrahydroxy-2, 2 -bipyridine-n, n-dioxides for the treatment of renal cell carcinoma 3344--22--nn-
UA43391U (en) 2-(5-r-aryl-1,2,4-triazole-3-ylthio)acetates that reduce level of triglycerides in blood serum
NZ608708A (en) Novel gpr 119 agonists
MY183201A (en) Processes for the preparation of 2-(1-phenylethyl)isoindolin-1-one compounds
HK1175781A1 (en) Process for the preparation of 5-(2-amino-pyrimidin-4-yl)-2-aryl-1h- pyrrole-3-carbox-amides 5-(2---4-)-2--1h--3-
MX2012003290A (en) Composition for lowering blood uric acid level.
UA37927U (en) Morpholinium 2-(5-(4-pyridyl)-4-(2-methoxyphenyl)-1,2,4-triazole-3-ylthio)acetate having antioxidant and detoxifying activity
UA37922U (en) Morpholinium 2-(5-(4-pyridyl)-4-(2-methoxyphenyl)-1,2,4-triazole-3-ylthio)acetate having antihypoxic activity with thermal protective properties and dosage forms thereof
EP2451803A4 (en) Method for preparing 5-chloro-n-({(5s)-2-oxo-3-[4-(5,6-dihydro-4h-[1,2,4]triazin-1-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophen-2-carboxamide derivative and intermediate used therein
Seo et al. An Experiment on the Acoustic Properties of Ceramic Materials
Yun Focus-Bukchon in Seoul, Is it all right as is?